Welcome to LookChem.com Sign In|Join Free

CAS

  • or

143097-60-3

Post Buying Request

143097-60-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143097-60-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 143097-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,0,9 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 143097-60:
(8*1)+(7*4)+(6*3)+(5*0)+(4*9)+(3*7)+(2*6)+(1*0)=123
123 % 10 = 3
So 143097-60-3 is a valid CAS Registry Number.

143097-60-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (±)-2-methyl-5-phenylpentanoic acid

1.2 Other means of identification

Product number -
Other names 2-methyl-5-phenylvaleric acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143097-60-3 SDS

143097-60-3Relevant articles and documents

Conjugate addition of a primary carbon radical to α,β-unsaturated carboxylic acids

Wu, Baogen,Avery, Bonnie A.,Avery, Mitchell A.

, p. 3797 - 3800 (2000)

Triethylborane in the presence of trace oxygen was employed simultaneously as a radical initiator and carboxyl protecting group to promote the conjugate radical addition of 2-phenethyl iodide to α,β- unsaturated carboxylic acids in good yields. (C) 2000 Elsevier Science Ltd.

METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH

-

Paragraph 0665-0666, (2015/02/02)

The present invention relates to novel bone compositions for locally delivering a therapeutic agent to the site of a bone defect. Therapeutic agents may promote repair of the bone defect and/or treat conditions or disorders such as pain, inflammation, cancer, and infection. The compositions include calcium phosphate cements and a demineralized bone matrix or a collagen sponge. The compositions are useful for implantation in a patient at the site of a bone defect.

METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG

-

Paragraph 00437; 00438, (2014/09/29)

The present invention relates to processes and intermediates for preparing compounds of formula (IA), wherein R1, R4, R5, R6, and L1 are as defined herein. Compounds of formula (IA) have been found useful as EP4 receptor agonists useful in the treatment of glaucoma, osteoporosis, neuropathic pain, and related disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 143097-60-3